Coeptis Therapeutics Holdings, Inc. (COEP)
Apr 24, 2026 - COEP merged into ZSQR
16.40
+0.19 (1.17%)
Inactive · Last trade price on Apr 24, 2026

COEP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1028212283094
Market Cap Growth
193.85%603.61%-57.98%-7.56%-68.04%191.32%
Enterprise Value
96.4876.312.9527.4228.1995.64
Last Close Price
16.4014.255.5015.6830.63200.00
PS Ratio
74.8860.08---1250.00
PB Ratio
6.956.043.4434.036.7339.88
P/TBV Ratio
5.124.453.1324.748.8446.43
EV/Sales Ratio
70.7955.98---1275.17
Debt / Equity Ratio
0.000.00-0.011.460.451.73
Net Debt / Equity Ratio
-0.45-0.450.26-0.30-0.390.81
Net Debt / EBITDA Ratio
0.520.52-0.100.010.05-0.14
Net Debt / FCF Ratio
0.710.71-0.130.030.45-0.42
Asset Turnover
0.110.110000.00
Quick Ratio
7.587.580.210.501.750.79
Current Ratio
8.778.770.420.591.810.79
Return on Equity (ROE)
11.57%11.57%22.13%-807.49%-1104.48%-47.94%
Return on Assets (ROA)
-104.09%-104.09%-149.18%-344.22%-465.85%-33.65%
Return on Invested Capital (ROIC)
-143.50%-143.50%-211.63%-864.89%-844.74%-35.09%
Return on Capital Employed (ROCE)
-120.12%-120.12%-251.85%-586.75%-701.91%-34.81%
Buyback Yield / Dilution
-120.03%-120.03%-49.84%0.00%-135.37%0.00%
Total Shareholder Return
-120.03%-120.03%-49.84%0.00%-135.37%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q